tradingkey.logo

Anbio Biotechnology

NNNN
Ver gráfico detallado
25.650USD
+1.590+6.61%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
1.13BCap. mercado
416.53P/E TTM

Anbio Biotechnology

25.650
+1.590+6.61%
Intraday
1m
30m
1h
D
W
M
D

Hoy

+6.61%

5 Días

+17.07%

1 Mes

-20.07%

6 Meses

-42.42%

Año hasta la fecha

-14.70%

Un año

0.00%

Ver gráfico detallado

Puntuación de acciones TradingKey

No hay puntuación de la acción disponible debido a la falta de datos.

Anbio Biotechnology Noticias

Próximamente más noticias, permanezca atento...

Indicadores financieros

BPA

La empresa aún no ha revelado los datos relevantes.

Ingresos totales

La empresa aún no ha revelado los datos relevantes.

Información de Anbio Biotechnology

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
Símbolo de cotizaciónNNNN
CompañíaAnbio Biotechnology
Director ejecutivoLau (Michael)
Sitio Webhttps://anbiobiotechnology.com/
KeyAI